FDA Authorizes First At-Home Coronavirus Self-Swab Test—But It Won't Be Available to Everyone

  • 📰 TIMEHealth
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The test from LabCorp will initially only be available to health care workers and first responders under a doctor's orders

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows 2019-nCoV, the virus causes COVID-19. — U.S. health regulators on Tuesday OK’d the first coronavirus test that allows people to collect their own sample at home, a new approach that could help expand testing options in most states.

Allowing people to self-swab at home would help reduce infection risks for front-line health care workers and help conserve protective gear. The company said it will make the test available in the coming weeks. Each kit will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

POTUS

Rich people can get them while I worry about feeding my kids. 😩

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 121. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Coronavirus cases are likely 10 to 20 times higher in US than reported, former FDA chief Gottlieb saysHealth experts say there needs to be much more Covid-19 testing to better monitor the spread of coronavirus as states seek to reopen businesses and social settings 50 times higher than US reported This isn’t about testing but identifying high risk patients. The CFR for high risk patients is about 5-10% as per Dr. Zalenko. We need to focus on who identifying and protecting this population, as well as tailoring therapies for them ex, Zalenko protocol. Of course, considering the strong likelihood that the virus was probably around undetected during the holiday season.
Source: CNBC - 🏆 12. / 72 Read more »